Document is current
Any future updates will be listed below
-
Authors
Brezani, Veronika
Joshi, Radhika S.
Ortega-Ribera, Marti
Nagesh, Prashanth Thevkar
Brezani, Viliam
Zivny, Adam
Kurt-Jones, Evelyn A.
Golenbock, Douglas T.
Szabo, Gyongyi
-
Funding
Funding for this research was provided by:
NIAAA (5R01AA017729)
NIH (5R01AG072899)
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 25 June 2025
First Online: 15 July 2025
Declarations
:
: All the mice breeding, experimental protocols, and euthanasia were conducted as per the institutional ethics and Institutional Animal Care and Use Committee (IACUC) approved protocols No. 019–2019, 030–2022, and 051–2024.
: G.S. is scientific consultant for Cyta Therapeutics, Durect, Evive, Pandion Therapeutics, Pfizer, Surrozen, Boehringer Ingelheim, Novo Nordisk, Resolution therapeutics and also holds equity in Glympse Bio, Zomagen and Satellite Bio. She received royalties from UptoDate and Springer. The remaining authors have no competing interests to report.
